VANCOUVER, BC / ACCESSWIRE / November 2, 2016 / CVR Medical Corp. (CVM.V) (“CVR Medical“) has entered into agreements with Tekna Incorporated, who will design and manufacture the cart for its “Carotid Stenotic Scan” (CSS) device.
Tekna, Inc. is a Southwest Michigan-based product development firm and ISO 13485 certified medical device manufacturer. Its diverse list of clients includes some of the most well known brands in contemporary technology. From their dual state-of-the-art facilities, they provide concept-to-distribution solutions that will help ensure full realization of CVR Global and CVR Medical’s groundbreaking instrument. The relationship marks a pivotal step in that process, and is a source of great confidence and excitement for both companies.
Tekna, Inc. Vice President Mike Rozewicz states, “As a design-focused organization with over 30 years of experience with medical devices, we really aim to impact peoples’ lives. We pride ourselves on having capabilities not found anywhere else in the U.S., especially in the clinical environment, where we have developed over 400 products. We are thrilled to work with CVR on a project that we believe will have a profound effect on stenosis and stroke prevention.”
Tekna’s core competencies of engineering and logistical management are rooted in a history of award-winning cart design and prototype pilot testing to meet FDA standards. CVR will leverage these capabilities, along with Tekna’s unique in-house branding services, to prepare a clear path to commercialization of the CSS device.
For additional information on the organization, leadership, and current news please visit the newly launched company website www.CVRMed.com
About CVR Medical
CVR Medical is a company that is involved in an equal parts joint venture with CVR Global Inc. (the “Joint Venture”). The Joint Venture operates in the medical industry focused on the commercialization of a proprietary subsonic, infrasonic, and low frequency sound wave analysis technology and has patents to a diagnostic device designed to detect and measure carotid arterial stenosis. CVR Medical is managed by a proven technical team. CVR Medical trades on the TSX Venture Exchange under the symbol CVM.
ON BEHALF OF THE BOARD:
(signed) “Peter Bakema”
CEO, President & Director
For further information contact:
Peter Bakema, CEO, President and Director
Telephone: (734) 718-5115
Email: info@cvrmed.com
or
Brisco Capital Partners Corp.
Scott Koyich, President
Telephone: (403) 262-9888
